[Skip to Content]
[Skip to Content Landing]
January 6, 1975

Medical News

JAMA. 1975;231(1):9-18. doi:10.1001/jama.1975.03240130003001

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


First clinical trial brings hope of effective psoriasis therapy  Combination therapy with oral 8-methoxypsoralen (methoxsalen), a photoactive drug, and long wave length ultra-violet light is being used successfully to treat psoriasis patients at Massachusetts General Hospital, in Boston, and the Allgemeines Krankenhaus, in Vienna.The results are preliminary and require further confirmation, even though recent newspaper headlines acclaiming this treatment as a "new cure for psoriasis" have caused quite a stir among the public. The headlines resulted in countless phone calls to physicians from anxious patients, and some criticism from academicians who told Medical News that the research was publicized prematurely outside the medical community. The newspaper story appeared the day before the original article in the December 5 New England Journal of Medicine.In order to set the record straight and put the new treatment in perspective the investigative team presented their results at a press conference during